Misdiagnosed myocarditis in arrhythmogenic cardiomyopathy induced by a homozygous variant of DSG2: a case report

Background Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy that is rarely diagnosed in infants or young children. However, some significant homozygous or compound heterozygous variants contribute to more severe clinical manifestations. In addition, inflammation of the myocardium and ventricular arrhythmia might lead to misdiagnosis with myocarditis. Here, we describe an 8-year-old patient who had been misdiagnosed with myocarditis. Timely genetic sequencing helped to identify this case as ACM induced by a homozygous variant of DSG2. Case presentation The proband of this case was an 8-year-old boy who initially presented with chest pain with an increased level of cardiac Troponin I. In addition, the electrocardiogram revealed multiple premature ventricular beats. Cardiac magnetic resonance revealed myocardial edema in the lateral ventricular wall and apex, indicating localized injuries of the myocardium. The patient was primarily suspected to have acute coronary syndrome or viral myocarditis. Whole-exome sequencing confirmed that the proband had a homozygous variation, c.1592T > G, of the DSG2 gene. This mutation site was regulated by DNA modification, which induced amino acid sequence changes, protein structure effects, and splice site changes. According to MutationTaster and PolyPhen-2 analyses, the variant was considered a disease-causing mutation. Next, we used SWISS-MODEL to illustrate the mutation site of p.F531C. The ensemble variance of p.F531C indicated the free energy changes after the amino acid change. Conclusion In summary, we reported a rare pediatric case initially presenting as myocarditis that transitioned into ACM during follow-up. A homozygous genetic variant of DSG2 was inherited in the proband. This study expanded the clinical feature spectrum of DSG2-associated ACM at an early age. Additionally, the presentation of this case emphasized the difference between homozygous and heterozygous variants of desmosomal genes in disease progression. Genetic sequencing screening could be helpful in distinguishing unexplained myocarditis in children.

[1]  D. Pennell,et al.  Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy , 2022, Circulation.

[2]  Yue Zhang,et al.  Acute coronary syndrome in an 8-year-old child with familial hypercholesterolemia: a case report , 2022, Journal of Medical Case Reports.

[3]  S. Boonyaratavej,et al.  Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy , 2021, BMC Cardiovascular Disorders.

[4]  D. Kelsell,et al.  Early inflammation precedes cardiac fibrosis and heart failure in desmoglein 2 murine model of arrhythmogenic cardiomyopathy , 2021, Cell and Tissue Research.

[5]  M. Massin,et al.  Association of left ventricular non-compaction with acute coronary syndrome , 2021, Acta cardiologica.

[6]  K. Klingel,et al.  Hemi- and Homozygous Loss-of-Function Mutations in DSG2 (Desmoglein-2) Cause Recessive Arrhythmogenic Cardiomyopathy with an Early Onset , 2021, International journal of molecular sciences.

[7]  H. Calkins,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Clinical Myocarditis in Women. , 2021, The American journal of cardiology.

[8]  S. Priori,et al.  Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy , 2020, Circulation.

[9]  M. Deutsch,et al.  A homozygous DSC2 deletion associated with arrhythmogenic cardiomyopathy is caused by uniparental isodisomy. , 2020, Journal of molecular and cellular cardiology.

[10]  D. Judge,et al.  Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy. , 2019, Circulation.

[11]  M. Halushka,et al.  Genetic aetiologies should be considered in paediatric cases of acute heart failure presumed to be myocarditis , 2019, Cardiology in the Young.

[12]  W. Pu,et al.  Molecular mechanisms of arrhythmogenic cardiomyopathy , 2019, Nature Reviews Cardiology.

[13]  Y. Hata,et al.  Minimal inflammatory foci of unknown etiology may be a tentative sign of early stage inherited cardiomyopathy , 2019, Modern Pathology.

[14]  J. Casanova,et al.  Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis. , 2017, Journal of the American College of Cardiology.

[15]  Paul M. K. Gordon,et al.  Transgenic mice overexpressing desmocollin-2 (DSC2) develop cardiomyopathy associated with myocardial inflammation and fibrotic remodeling , 2017, PloS one.

[16]  B. Honig,et al.  Structural basis of adhesive binding by desmocollins and desmogleins , 2016, Proceedings of the National Academy of Sciences.

[17]  R. Hauer,et al.  Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With Adult-Onset Disease. , 2015, JACC. Clinical electrophysiology.

[18]  M. J. Oliva-Sandoval,et al.  Genetics of myocarditis in arrhythmogenic right ventricular dysplasia. , 2015, Heart rhythm.

[19]  H. Duff,et al.  Phenotypic Analysis of Arrhythmogenic Cardiomyopathy in the Hutterite Population: Role of Electrocardiogram in Identifying High‐Risk Desmocollin‐2 Carriers , 2014, Journal of the American Heart Association.

[20]  R. Hauer,et al.  Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. , 2015, European heart journal.

[21]  Elizabeth R. Duffy,et al.  Altered Desmosomal Proteins in Granulomatous Myocarditis and Potential Pathogenic Links to Arrhythmogenic Right Ventricular Cardiomyopathy , 2011, Circulation. Arrhythmia and electrophysiology.

[22]  L. Jordaens,et al.  Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study , 2011, Circulation.

[23]  P. Elliott,et al.  Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria , 2011, Circulation.

[24]  J. Deharo,et al.  Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. , 2010, Europace.

[25]  S. Scherer,et al.  Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[26]  Dudley J Pennell,et al.  Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.

[27]  A. Angelini,et al.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.

[28]  OUP accepted manuscript , 2022, Cardiovascular Research.

[29]  Jiangping Song,et al.  A founder homozygous DSG2 variant in East Asia results in ARVC with full penetrance and heart failure phenotype. , 2019, International journal of cardiology.

[30]  D. Corrado,et al.  Arrhythmogenic Cardiomyopathy. , 2017, Circulation research.

[31]  P. Elliott,et al.  Impact of Genetics and Revised Task Force Criteria Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy , 2011 .

[32]  D. C. Henckel,et al.  Case report. , 1995, Journal.